Leidos Holdings CapEx decreased by 27.9% to $31.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 40.9%, from $22.00M to $31.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 4.7% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.00M | $21.00M | $24.00M | $33.00M | $28.00M | $21.00M | $27.00M | $53.00M | $39.00M | $40.00M | $50.00M | $78.00M | $17.00M | $23.00M | $23.00M | $86.00M | $22.00M | $29.00M | $31.00M | $43.00M | $31.00M |
| QoQ Change | — | -19.2% | +14.3% | +37.5% | -15.2% | -25.0% | +28.6% | +96.3% | -26.4% | +2.6% | +25.0% | +56.0% | -78.2% | +35.3% | +0.0% | +273.9% | -74.4% | +31.8% | +6.9% | +38.7% | -27.9% |
| YoY Change | — | — | — | — | +7.7% | +0.0% | +12.5% | +60.6% | +39.3% | +90.5% | +85.2% | +47.2% | -56.4% | -42.5% | -54.0% | +10.3% | +29.4% | +26.1% | +34.8% | -50.0% | +40.9% |